Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years.
- 1 January 1985
- journal article
- Vol. 132 (1) , 19-23
Abstract
This paper describes the Adverse Drug Reaction Reporting Program developed and operated by the Committee on Drugs and Pharmaco-therapy of the Ontario Medical Association. Analyses were done to demonstrate some of the trends derived from the reports. Some of the clinical observations based on the reports, which are published quarterly and circulated to physicians and to pharmacy, nursing and hospital organizations, are also reviewed.This publication has 14 references indexed in Scilit:
- Adverse effects of NSAIDs on renal function.1984
- Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methodsJAMA, 1983
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.BMJ, 1981
- Adverse drug reactions: uncommon or unrecognized?1979
- Drug Evaluation After MarketingAnnals of Internal Medicine, 1979
- WHEN IS A CLINICAL EVENT AN ADVERSE DRUG REACTION1978
- Adverse drug reactions and death. A review of 827 casesJAMA, 1976
- Adverse drug reactions. A critical review.1975
- Fatal Reactions to Drug TherapyNew England Journal of Medicine, 1974